We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current HBP market cap is 41M. The company's latest EPS is CAD -0.0314 and P/E is -6.37.
Year End 31 July 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -7.49M | -8.62M | -9.13M | -5.87M | -6.22M |
Net Income | -7.53M | -9.17M | -8.04M | -6.56M | -6.29M |
Year End 31 July 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Assets | 940k | 4.91M | 4.07M | 3.73M | 1.03M |
Total Liabilities | 4.22M | 1.93M | 5.46M | 3.41M | 1.87M |
Total Equity | -3.28M | 2.98M | -1.39M | 319k | -844k |
Year End 31 July 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Operating | -5.53M | -10.83M | -9.3M | -6.51M | -5.53M |
Investing | -4k | 1.7M | 2.02M | N/A | -5k |
Financing | 5.41M | 13.1M | 6.56M | 6.21M | 3.09M |
Market Cap | 41M |
Price to Earnings Ratio | -6.37 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 50 |
Price to Book Ratio | -47.4 |
Dividend Yield | - |
Shares Outstanding | 200.02M |
Average Volume (1 week) | 44.02k |
Average Volume (1 Month) | 18.5k |
52 Week Change | 2.50% |
52 Week High | 0.26 |
52 Week Low | 0.15 |
Spread (Intraday) | 0.01 (4.35%) |
Company Name | Helix BioPharma Corp |
Address |
2704, 401 bay street toronto, ontario M5H 2Y4 |
Website | https://www.helixbiopharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions